Cargando…
A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics
OBJECTIVES: We examined whether plasma concentrations of amyloid beta (Aβ) as protein derivatives play a central role in the etiology of autistic features. DESIGN AND METHODS: Concentrations of human Aβ (1-42), Aβ (1-40), and Aβ (40/42) in the plasma of 52 autistic children (aged 3-16 years) and 36...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398286/ https://www.ncbi.nlm.nih.gov/pubmed/22239861 http://dx.doi.org/10.1186/1744-9081-8-4 |
_version_ | 1782238266616971264 |
---|---|
author | Al- Ayadhi, Laila Y Ben Bacha, Abir G Kotb, Malak El-Ansary, Afaf K |
author_facet | Al- Ayadhi, Laila Y Ben Bacha, Abir G Kotb, Malak El-Ansary, Afaf K |
author_sort | Al- Ayadhi, Laila Y |
collection | PubMed |
description | OBJECTIVES: We examined whether plasma concentrations of amyloid beta (Aβ) as protein derivatives play a central role in the etiology of autistic features. DESIGN AND METHODS: Concentrations of human Aβ (1-42), Aβ (1-40), and Aβ (40/42) in the plasma of 52 autistic children (aged 3-16 years) and 36 age-matched control subjects were determined by using the ELISA technique and were compared. RESULTS: Compared to control subjects, autistic children exhibited significantly lower concentrations of both Aβ (1-40) and Aβ (1-42) and lower Aβ (40/42) concentration ratio. Receiver operating characteristics curve (ROC) analysis showed that these measurements of Aβ peptides showed high specificity and sensitivity in distinguishing autistic children from control subjects. CONCLUSIONS: Lower concentrations of Aβ (1-42) and Aβ (1-40) were attributed to loss of Aβ equilibrium between the brain and blood, an imbalance that may lead to failure to draw Aβ from the brain and/or impairment of β- and γ- secretase's concentration or kinetics as enzymes involving in Aβ production. |
format | Online Article Text |
id | pubmed-3398286 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-33982862012-07-18 A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics Al- Ayadhi, Laila Y Ben Bacha, Abir G Kotb, Malak El-Ansary, Afaf K Behav Brain Funct Research OBJECTIVES: We examined whether plasma concentrations of amyloid beta (Aβ) as protein derivatives play a central role in the etiology of autistic features. DESIGN AND METHODS: Concentrations of human Aβ (1-42), Aβ (1-40), and Aβ (40/42) in the plasma of 52 autistic children (aged 3-16 years) and 36 age-matched control subjects were determined by using the ELISA technique and were compared. RESULTS: Compared to control subjects, autistic children exhibited significantly lower concentrations of both Aβ (1-40) and Aβ (1-42) and lower Aβ (40/42) concentration ratio. Receiver operating characteristics curve (ROC) analysis showed that these measurements of Aβ peptides showed high specificity and sensitivity in distinguishing autistic children from control subjects. CONCLUSIONS: Lower concentrations of Aβ (1-42) and Aβ (1-40) were attributed to loss of Aβ equilibrium between the brain and blood, an imbalance that may lead to failure to draw Aβ from the brain and/or impairment of β- and γ- secretase's concentration or kinetics as enzymes involving in Aβ production. BioMed Central 2012-01-13 /pmc/articles/PMC3398286/ /pubmed/22239861 http://dx.doi.org/10.1186/1744-9081-8-4 Text en Copyright ©2012 Al- Ayadhi et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Al- Ayadhi, Laila Y Ben Bacha, Abir G Kotb, Malak El-Ansary, Afaf K A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics |
title | A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics |
title_full | A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics |
title_fullStr | A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics |
title_full_unstemmed | A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics |
title_short | A novel study on amyloid β peptide 40, 42 and 40/42 ratio in Saudi autistics |
title_sort | novel study on amyloid β peptide 40, 42 and 40/42 ratio in saudi autistics |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398286/ https://www.ncbi.nlm.nih.gov/pubmed/22239861 http://dx.doi.org/10.1186/1744-9081-8-4 |
work_keys_str_mv | AT alayadhilailay anovelstudyonamyloidbpeptide4042and4042ratioinsaudiautistics AT benbachaabirg anovelstudyonamyloidbpeptide4042and4042ratioinsaudiautistics AT kotbmalak anovelstudyonamyloidbpeptide4042and4042ratioinsaudiautistics AT elansaryafafk anovelstudyonamyloidbpeptide4042and4042ratioinsaudiautistics AT alayadhilailay novelstudyonamyloidbpeptide4042and4042ratioinsaudiautistics AT benbachaabirg novelstudyonamyloidbpeptide4042and4042ratioinsaudiautistics AT kotbmalak novelstudyonamyloidbpeptide4042and4042ratioinsaudiautistics AT elansaryafafk novelstudyonamyloidbpeptide4042and4042ratioinsaudiautistics |